This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Colin McKinlay, PhD
Senior Director, Chemistry and Delivery Technology at Nutcracker Therapeutics


Dr. Colin McKinlay is the Senior Director of Chemistry and Delivery technologies at Nutcracker Therapeutics and oversees projects related to Nutcracker's Nutshell delivery platform. Dr. McKinlay has over 8 years of expertise in oligonucleotide delivery both at Nutcracker and through is doctoral research at Stanford University with Professors Paul Wender and Robert Waymouth. This research involved preparation of synthetic delivery vehicles through organocatalytic ring-opening polymerization, and their characterization and in vitro and in vivo evaluation for the delivery of DNA, RNA, and other biological macromolecules. He holds 6 patents and 8 peer-reviewed publications on chemical delivery technologies.

Agenda Sessions

  • Delivery in a Nutshell(TM): Activity-informed Design of Cationic Peptoids with Enhanced Efficacy for the Uptake and Expression of mRNA Therapeutics